×
Alcon Common Stock Net 2019-2025 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon common stock net for the quarter ending March 31, 2025 was
$20M
, a
0% increase
year-over-year.
Alcon common stock net for 2024 was
$0.02B
, a
0% decline
from 2023.
Alcon common stock net for 2023 was
$0.02B
, a
0% decline
from 2022.
Alcon common stock net for 2022 was
$0.02B
, a
0% decline
from 2021.
View More
Alcon Common Stock Net 2019-2025 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon common stock net for 2024 was
$0.02B
, a
0% decline
from 2023.
Alcon common stock net for 2023 was
$0.02B
, a
0% decline
from 2022.
Alcon common stock net for 2022 was
$0.02B
, a
0% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$171.7B
Intuitive Surgical (ISRG)
$168.4B
IDEXX Laboratories (IDXX)
$52B
Edwards Lifesciences (EW)
$45.8B
IQVIA Holdings (IQV)
$30.4B
DexCom (DXCM)
$30B
Mettler-Toledo (MTD)
$25.5B
STERIS (STE)
$23.2B
Waters (WAT)
$16.5B
SONOVA HOLDING (SONVY)
$16.4B
Hologic (HOLX)
$15.1B
Penumbra (PEN)
$9.4B
Sysmex ADR (SSMXY)
$8.6B
Masimo (MASI)
$7.9B
Globus Medical (GMED)
$7.3B
Teleflex (TFX)
$5.1B
Glaukos (GKOS)
$5B
TransMedics (TMDX)
$4B
Integer Holdings (ITGR)
$3.7B
LivaNova (LIVN)
$2.6B
Alphatec Holdings (ATEC)
$2.2B
PROCEPT BioRobotics (PRCT)
$2.2B
Veracyte (VCYT)
$2.2B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.9B
Artivion (AORT)
$1.4B
Paragon 28 (FNA)
$1.1B
Pulse Biosciences (PLSE)
$990M
Integra LifeSciences Holdings (IART)
$984M
OPKO Health (OPK)
$976M